MULTIPLE SCLEROSIS AND RELATED DISORDERS

Visão geral
Metrics
Identidade
Ver todos

Qualis

A4

código do país

NL

tipo

journal

publicação venue de

A coffee enriched with guarana, selenium, and L-carnitine (GSC) has nutrigenomic effects on oxi-inflammatory markers of relapsing-remitting multiple sclerosis patients: a pilot study. 1:104515-104524. 2023-01-01
A comparative study of visual outcome in patients with optic neuritis treated with five or seven days of intravenous corticosteroid treatment. 75:104737. 2023-01-01
Are we ready to define cognitive worsening in MS? How different cutoffs detect future cognitive worsening after six years of follow-up. 69:104402. 2023-01-01
Cost, efficacy, and safety comparison between early intensive and escalating strategies for multiple sclerosis: A systematic review and meta-analysis. 71:104581. 2023-01-01
Estimated prevalence of AQP4 positive neuromyelitis optica spectrum disorder and MOG antibody associated disease in São Paulo, Brazil. 70:104488. 2023-01-01
Higher frequency of Human herpesvirus-6 (HHV-6) viral DNA simultaneously with low frequency of Epstein-Barr virus (EBV) viral DNA in a cohort of multiple sclerosis patients from Rio de Janeiro, Brazil. 1:1-10. 2023-01-01
Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs. 77:104840. 2023-01-01
Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients. 75:104730. 2023-01-01
Obesity increases blood-brain barrier permeability and aggravates the mouse model of multiple sclerosis. 1:104605-20. 2023-01-01
Reliability of the five times sit to stand test performed remotely by multiple sclerosis patients. 73:104654. 2023-01-01
Therapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America. 71:104508. 2023-01-01
Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosis. 75:104733. 2023-01-01
'Dry oral and ocular manifestations and autoantibodies characteristic of primary Sjögren's syndrome in multiple sclerosis'. 62:103783. 2022-01-01
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.. 1:103909-103915. 2022-01-01
Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD. 01:104215. 2022-01-01
Bilateral coordination of gait at self-selected and fast speed in patients with multiple sclerosis: a case-control study.. Jul:104027-1. 2022-01-01
Blood levels of brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis (MS): A systematic review and meta-analysis. 65:103984. 2022-01-01
Depressive symptoms, fatigue and the level of physical activity during perimenopause in women with multiple sclerosis. 67:2-2. 2022-01-01
Fatal Neuromyelitis Optica after COVID-19 vaccination. 1:104089. 2022-01-01
Functions of astrocytes in multiple sclerosis: A review. 60:103749. 2022-01-01
Is BDNF related to spatial-temporal gait parameters in people with multiple sclerosis? An observational study. 66:104064. 2022-01-01
Monkeypox in Multiple Sclerosis patients: should we be alert?. 66:1-2. 2022-01-01
Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group. 59:103649-103655. 2022-01-01
Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales. 58:103495. 2022-01-01
Relationship between zinc-related nutritional status and the progression of multiple sclerosis. 66:1-5. 2022-01-01
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. 66:104072. 2022-01-01
Social Cognitive Theory variables as correlates of physical activity in fatigued persons with multiple sclerosis. 57:103312. 2022-01-01
Accuracy of the Brazilian version of the DYMUS questionnaire for the screening of oropharyngeal dysphagia in multiple sclerosis. 50:102772. 2021-01-01
COVID-19 in a temporal relation to the onset of multiple sclerosis. 50:102863-102863. 2021-01-01
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America. 3:102886. 2021-01-01
Can dexamethasone prevent the seizures induced by SARS-CoV-2 infection?. 47:102606. 2021-01-01
Cardiovascular risk estimated in individuals with multiple sclerosis: A case-control study. 54:103133. 2021-01-01
Coronavirus disease 2019 in Latin American patients with multiple sclerosis. 55:103173-103173. 2021-01-01
Cytotoxic profile of CD3+CD20+ T cells in progressive multiple sclerosis. 52:103013. 2021-01-01
Demographic, clinical, and symptomatic correlates of subjective sleep quality in adults with multiple sclerosis. 55:103204. 2021-01-01
Drug-related demyelinating syndromes: understanding risk factors, pathophysiological mechanisms and magnetic resonance imaging findings. 55:103146. 2021-01-01
Effectiveness of Virtual Reality Rehabilitation in Persons with Multiple Sclerosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. 54:103128-103136. 2021-01-01
Effects of hippotherapy on postural balance, functional mobility, self-perceived fatigue, and quality of life in people with relapsing-remitting multiple sclerosis: Secondary results of an exploratory clinical trial. 52:102948. 2021-01-01
Excess weight, central adiposity and pro-inflammatory diet consumption in patients with neuromyelitis optica spectrum disorder. 1:103110-1. 2021-01-01
Human endogenous retrovirus and multiple sclerosis: a review and transcriptome findings. 57:103383. 2021-01-01
Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: A systematic review. 55:103184. 2021-01-01
Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis. 01:103407. 2021-01-01
Multiple Sclerosis does not affect the muscular strength of the pelvic floor during pregnancy a case control study.. 1:102746-102746. 2021-01-01
Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study. 57:103331. 2021-01-01
Myelopathies in patients older than 50: not to miss inflammatory etiologies.. 50:102826. 2021-01-01
Myelorradiculitis due to Varicella Zoster (Elsberg syndrome) as the first symptom of HIV in a patient with Crohn's disease in use of Infliximab. 47:102643. 2021-01-01
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19. 1:103321-103323. 2021-01-01
Optic neuritis in Asian type opticospinal multiple sclerosis (OSMS-ON) in a non-Asian population: A functional-structural paradox. 56:103260-8. 2021-01-01
Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges. 50:102806. 2021-01-01
Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil. 50:102. 2021-01-01
Reduced quality of life in a pediatric-onset Neuromyelitis Optica spectrum disorders cohort. 1:103252. 2021-01-01
Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care. 53:103038. 2021-01-01
STATUS OF THE NEUROMIELITIS SPECTRUM DISORDER IN LATIN AMERICA. 1:103083. 2021-01-01
Speech discrimination impairments as a marker of disease severity in multiple sclerosis. 47:102608. 2021-01-01
Treatment of MOG-IgG associated disease in paediatric patients: a systematic review. 1:103216. 2021-01-01
Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases. 44:102181. 2020-01-01
Acute effects of whole-body vibration training on neuromuscular performance and mobility in hypoxia and normoxia in persons with multiple sclerosis: A crossover study. 37:101454. 2020-01-01
Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study. 46:102558. 2020-01-01
Associations between cognitive and clinical disability across MS subtypes: the role of the underlying brain damage. 48:102701. 2020-01-01
Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population. 42:102049. 2020-01-01
CLINICAL course of acute disseminated encephalomyelitis in adults from Rio de Janeiro: Retrospective study of 23 cases and literature review. 46:102424. 2020-01-01
Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays. 38:101858. 2020-01-01
Does oral salbutamol improve fatigue in multiple sclerosis? A pilot placebo-controlled study. 46:102586. 2020-01-01
Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis. 1:102203-0. 2020-01-01
Efficacy outcomes reported in trials of multiple sclerosis: a systematic scoping review. 1:102435-16. 2020-01-01
Exploring the performance of outcome measures in MS for predicting cognitive and clinical progression in the following years. 46:102513. 2020-01-01
Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?. 42:102082-x. 2020-01-01
Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOGIgG related disease?. 42:102082. 2020-01-01
Is Asian type MS an NMO spectrum disorder, or a MOG-IgG related disease. 1:1-1. 2020-01-01
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice. 45:102428. 2020-01-01
Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis. 41:102029. 2020-01-01
OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas. 40:101984. 2020-01-01
Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis T optica spectrum disorders. 41:1-5. 2020-01-01
Restless legs syndrome, sleep quality, and perceived cognitive impairment in adults with multiple sclerosis. 43:102176. 2020-01-01
Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients. 1:102251. 2020-01-01
Urinary tract infection in patients with multiple sclerosis: An overview. 46:102462. 2020-01-01
Whole Transcriptome analysis of Multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases. 1:102243-1. 2020-01-01

tem uma área de assunto

publisher

Elsevier BV

is open access

False invalid format

is in DOAJ

False invalid format